Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Human Phase 1 Study of AOH1996 in Patients With Refractory Solid Tumors

NCT05227326 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT05227326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05227326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Human Phase 1 Study of AOH1996 in Patients With Refractory Solid Tumors
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Recruiting
Start date
August 12, 2022
Completion date
September 13, 2029
Enrollment
92 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

leiomyosarcomas, non-small cell lung cancer, osteosarcoma, ovarian cancer, pancreatic cancer, refractory malignant solid neoplasm, synovial sarcomas